Sezary Syndrome clinical trials

Explore recruiting sezary syndrome clinical trials.

Recruiting sezary syndrome studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Sezary Syndrome trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Open-Label, Phase 2 Study to Assess the Safety of Mogamulizumab Given Every 4 Weeks Following Induction in Participants with Relapsed/Refractory Cutaneous T-Cell Lymphoma (CTCL)

Spain, France

Therapeutic exploratory (Phase II) EU CTIS Study details

TELLOMAK: T-cell Lymphoma anti-KIR3DL2 therapy. An open label, multi-cohort, multi-center phase II study evaluating the efficacy and safety of IPH4102 alone or in combination with chemotherapy in patients with advanced T-cell lymphoma.

France, Belgium, Spain, Poland, Italy, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

EORTC 1820-CLTF: Open-Label, phase II, Multi-Center, study of Anti-CCR4 Monoclonal Antibody (mogamulizumab) Plus Total Skin Electron Beam therapy (TSEB) in patients with stage IB-IIB Cutaneous T-Cell Lymphoma (MOGAT)

Spain, Denmark, Italy, France, Germany, Greece

Therapeutic exploratory (Phase II) EU CTIS Study details

Sezary Syndrome trials by city

Sezary Syndrome in Toronto Sezary Syndrome in Vancouver Sezary Syndrome in Montreal Sezary Syndrome in Calgary Sezary Syndrome in Edmonton Sezary Syndrome in Ottawa Sezary Syndrome in Winnipeg Sezary Syndrome in Quebec City Sezary Syndrome in Hamilton Sezary Syndrome in Kitchener Sezary Syndrome in London Sezary Syndrome in Halifax Sezary Syndrome in New York Sezary Syndrome in Los Angeles Sezary Syndrome in Chicago Sezary Syndrome in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease